| Tuesday, March 16, 2021 |
Propofol Shortage Due to Covid-19
The unanticipated increased use of Propofol as a sedative for ventilated patients has strained the nation’s Propofol supply for intensive care units. As a result, the FDA has issued an Emergency Use Authorization (EUA)
for emergency use of the Propoven 2% Emulsion
to maintain sedation via continuous infusion in patients 16 years and older who require mechanical ventilation in an intensive care unit (ICU) during the COVID-19 pandemic.
What is the difference in 1% and 2%
1% = 10 mg per mL
2% = 20 mg per mL
The 2% Emulsion contains the same active ingredient, Propofol but in a higher concentration. Propofol 2% has double the concentration of Propofol.
*Please see the Institute for Safe Medication Practices (ISMP) Special Edition Newsletter
for further details.